ENOVIX INVESTORS: Contact Block & Leviton About Its Ongoing Investigation
Key Highlights
- ➤Enovix AI-1 cells missed their energy-density target
- ➤Enovix halted smartphone field testing for AI-1 cells
- ➤Enovix shifted development toward smart eyewear
- ➤Enovix announced restructuring cutting 220 positions
- ➤Enovix shares fell approximately 9% after the disclosure
BOSTON, MA / ACCESS Newswire / November 13, 2026 / Block & Leviton is investigating Enovix (NASDAQ:ENVX) for potential securities law violations. Investors who have lost money in their Enovix investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/envx. What is this all about?
Block & Leviton is investigating whether Enovix and certain of its executives misled investors about how close its AI-1 silicon-anode battery cells were to qualifying for use in smartphones. During 2026, management described smartphone qualification as nearly complete. In February, then-CEO Raj Talluri said customer samples had met energy-density requirements, and in August management said only one final accelerated cycle-life test remained. On November 12, 2026, alongside its third-quarter results, Enovix disclosed that its AI-1 cells had missed their energy-density target, that it would not proceed with smartphone field testing, and that it was shifting development toward smart eyewear; it also announced a restructuring cutting 220 positions. On this news, Enovix's stock fell approximately 9%.
Get started
Create a free account to read the full story.